Leads from the MMWR. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.
D002738:Chloroquine; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D004351:Drug Resistance; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D010963:Plasmodium falciparum; D011739:Pyrimethamine / Q000009:adverse effects* / Q000627:therapeutic use; D013413:Sulfadoxine / Q000009:adverse effects* / Q000627:therapeutic use; D013424:Sulfanilamides / Q000009:adverse effects*; D014195:Travel
D004338:Drug Combinations; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D002738:Chloroquine; D011739:Pyrimethamine